From the impact of Obamacare to cutting edge research, from biotech buyouts to big pharma court battles, the Motley Fool's health-care team sits down each week to discuss the most fascinating developments across the health-care industry, and their implications for long-term investors. In this week's edition, the team talks about big pharma patent disputes, stocks that have both popped and plummeted, and companies our analysts will be watching in the coming days.
Brenton Flynn has no position in any stocks mentioned. David Williamson owns shares of Pfizer. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool recommends Costco Wholesale, GlaxoSmithKline, Johnson & Johnson, and UnitedHealth Group. The Motley Fool owns shares of Costco Wholesale and Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
